Angiodynamics announces presentation of positive safety, efficacy results from rapid outcomes database

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced the safety and efficacy results from the registry of angiovac* system procedures in detail (rapid) database. results were shared by principal investigator john moriarty, md, fsir, fsvm (associate professor of radiology and medicine, cardiology—ucla interventional radiology, david geffen s
ANGO Ratings Summary
ANGO Quant Ranking